Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PRQR ProQR Therapeutics N.V. Ordinary Shares
$1.18 -16.31% -0.23
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRQR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

ProQR Therapeutics N.V. Ordinary Shares (PRQR)

Loading

Key Stats

Market cap. 166.8M
Enterprise value 99.3M
Trailing PE -2.9499998688698
Forward PE -3.1263857
PEG Ratio -3.1263857
Enterprise to EBITDA -2.151
Enterprise to revenue 4.891
Price to book MRQ 2.676111
Price to sales TTM 10.8166275

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 20.3M
EBITDA -46196116
Diluted EPS TTM -0.45
Total Cash (MRQ) 129.1M
Current ratio (MRQ) 3.488
Operating Cash Flow (TTM) -54029237

PRQR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRQR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.